Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis.

Inclusion Criteria: * Patients with otalgy or not, with acute external otitis ; * Patients with at least two symptoms of otalgy (pain, discharge, tinnitus, ear fullness, subjective hearing loss temporary dizziness or vertigo) with the Visual Analogic Scale score between 4 and 8 (mild to moderate); * The patient must present otalgia in one ear; * Children above 6 years of age; * Adults over 18 years of age; * Patients who consent to participate in the study; * Patients who are female and are of childbearing age should use reliable method of contraception and have negative pregnancy test. Exclusion Criteria: * Patients with sensitivity to any component of the formula; * Patients pregnant or lactating; * Non visualization of the tympanic membrane of obstruction by cerumen; * Patients with evidence of any wound or scratch on the ear (ulcerative lesion); * Patients who are making use of any other medication that might interfere with the evaluation of effectiveness of study (such as antibiotics, antiinflammatory, solutions ear); * Patients who have severe classification in the Visual Analogic Scale score 9 or 10 in any of the symptoms listed in the questionnaire; * Patients with otalgy not otological origin; * Patients with otitis, except acute external otitis ; * Patients who have epiglottitis; * The patient with infection; * Patients who can not follow the procedures clarified in this protocol.